Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 1/2 1

Status

Completed 3Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 2INDUSTRY 2NIH 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Arthritis, Rheumatoid 8Melanoma 7Colitis, Ulcerative 6Inflammatory Bowel Diseases 5Crohn Disease 5Colitis 4Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Urogenital Neoplasms 2Inflammation 2Hematologic Neoplasms 2Graft vs Host Disease 2Fatigue 2Depressive Disorder, Major 2Depression 2Cachexia 2Anorexia 2Vasculitis 1Takayasu Arteritis 1Syndrome 1Stroke 1Stevens-Johnson Syndrome 1Spondylitis, Ankylosing 1Skin Neoplasms 1Recurrence 1Rare Diseases 1Psoriasis 1Precancerous Conditions 1Pemphigoid, Benign Mucous Membrane 1Pancreatic Neoplasms 1

Interventions

Infliximab 5Tea 3Polyethylene Glycols 3Blood Specimen Collection 3Standard of Care 2MEDI2070 2Lidocaine 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Colonoscopy 2CT-P13 2Biopsy 2Adalimumab 2sodium phosphate 1purine 1prucalopride 1polyethylene glycol 400 1picosulfate sodium 1golimumab 1fumaric acid 1cabozantinib 1Tumor Necrosis Factor Inhibitors 1Thrombin Time 1Surveys and Questionnaires 1Surgical Tape 1Sulfasalazine 1Spectrum Analysis, Raman 1Specimen Handling 1Single-Balloon Enteroscopy 1Registries 1Proctocolectomy, Restorative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Inflammatory Bowel Diseases × Infliximab × Clear all
NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Janssen Scientific Affairs, LLC

Phase 4 Completed
1 enrolled 1 chart
Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

NCT04646187 2025-01-06

FREE

University Medical Center Groningen

Phase 4 Enrolling by invitation
148 enrolled

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

NCT03452501 2021-02-23

Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients

Hikma Pharmaceuticals LLC

Completed
157 enrolled

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

NCT00325078 2015-12-29

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
40 enrolled 11 charts

Crohn Disease, Granulomatous Disease, Chronic, Inflammatory Bowel Diseases

NCT02376478 2015-03-03

On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

Medical University of Vienna

Completed
222 enrolled

Psoriasis, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡